Press Releases on April 2, 2024 - EIN Presswire - Press Release Distribution Service

Published on April 2, 2024 - 20:05 GMT

MILLER/HOWARD HIGH INCOME EQUITY FUND UPDATES MONTHLY DISTRIBUTION INFORMATION FOR THE JUNE DISTRIBUTION TO TAKE INTO ACCOUNT ...

Kingston, NY, April 02, 2024 (GLOBE NEWSWIRE) -- The Board of Trustees of the Miller/Howard High Income Equity Fund (NYSE: HIE) (the “Fund”) declared, on April 1, 2024, cash distributions of $0.051 per share for each of April, May, and June 2024. Effective …

Distribution channels: Media, Advertising & PR ...

Published on April 2, 2024 - 20:05 GMT

Highwoods to Release First Quarter 2024 Results Tuesday, April 23rd

RALEIGH, N.C., April 02, 2024 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) will release its first quarter 2024 results on Tuesday, April 23rd, after the market closes. A conference call will be held the next day, Wednesday, April 24th, at 11: …

Distribution channels: Culture, Society & Lifestyle, Real Estate & Property Management ...

Published on April 2, 2024 - 20:05 GMT

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on April 1, 2024, the company issued inducement awards to …

Distribution channels: Technology ...

Published on April 2, 2024 - 20:05 GMT

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the appointment of Mehul Joshi as Chief …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on April 2, 2024 - 20:05 GMT

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor ...

NEW YORK and SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on April 2, 2024 - 20:05 GMT

Dave & Buster's Reports Fourth Quarter and Fiscal Year End 2023 Financial Results

DALLAS, April 02, 2024 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ: PLAY), ("Dave & Buster's" or "the Company"), an owner and operator of entertainment and dining venues, today announced financial …

Distribution channels:

Published on April 2, 2024 - 20:05 GMT

Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue

SEATTLE, April 02, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease …

Distribution channels: Companies, Media, Advertising & PR ...

Published on April 2, 2024 - 20:05 GMT

Marathon Digital Holdings Announces the Closing of its Acquisition of a 200-Megawatt Bitcoin Mining Data Center Adjacent to a Wind ...

Fort Lauderdale, FL, April 02, 2024 (GLOBE NEWSWIRE) -- Marathon Digital Holdings, Inc. (NASDAQ:MARA) ("Marathon" or "Company"), one of the world’s largest publicly traded Bitcoin miners and a leader in supporting and securing the …

Distribution channels:

Published on April 2, 2024 - 20:05 GMT

Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the ...

Clinical results demonstrate long-term efficacy of the OMNI® Surgical System for primary open-angle glaucoma and support use of TearCare® technology as a primary treatment for dry eye disease. MENLO PARK, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sight …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on April 2, 2024 - 20:05 GMT

Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives

IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), today announced the appointment of Tim Benner as Senior Vice President of U.S. Sales and Dr. Andrew Niekamp as Vice President of Medical Affairs. Mr. Benner …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 2, 2024 - 20:05 GMT

ContextLogic Announces Post-Closing Board of Directors and Management Team

Upon Closing, Rishi Bajaj to Become Chief Executive Officer of ContextLogic and Four New Independent Directors to Join ContextLogic Board Six Existing Directors to Step Down from Board Upon Completion of the Qoo10 Transaction Reconstituted Board and …

Distribution channels: Companies, Consumer Goods ...

Published on April 2, 2024 - 20:05 GMT

OneMedNet Announces CEO Succession Plan

~ President, Aaron Green, Assumes Role of Chief Executive Officer ~ ~ CEO, Paul Casey, Announces Retirement and Shift to Active Advisory Role to Guide Transition Successfully ~ ~ Casey to Remain on Board Post-Transition ~ MINNEAPOLIS, April 02, 2024 (GLOBE …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on April 2, 2024 - 20:03 GMT

PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare ...

SAN JOSE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will …

Distribution channels:

Published on April 2, 2024 - 20:02 GMT

Participants needed for Brock research linking allergies, asthma to childhood experiences

MEDIA RELEASE: April 1 2024 – R0042 The composition of good microbes harmoniously living in our bodies could be shaped by early childhood experiences, one of several physiological connections a Brock team is exploring in their research on allergies. …

Distribution channels:

Published on April 2, 2024 - 20:01 GMT

CBP Announces Trusted Traveler Programs Fee Changes

WASHINGTON — U.S. Customs and Border Protection (CBP) announced today an upcoming fee change for some of its most popular Trusted Traveler Programs (TTP). On April 2, a final rule was published in the Federal Register, harmonizing the fees for the NEXUS, …

Distribution channels:

Published on April 2, 2024 - 20:01 GMT

CBP Asks for Public Cooperation During "Eclipse Weekend" in Maine

Anticipating a large influx of tourists, CBP asks that individuals stay clear of Border Areas HOULTON, Maine – U.S. Customs and Border Protection (CBP) - comprised of Border Patrol, the Office of Field Operations, and Air and Marine Operations - requests …

Distribution channels:

Published on April 2, 2024 - 20:01 GMT

CBP officers seize $1.3M in methamphetamine at Colombia-Solidarity Bridge

LAREDO, Texas—U.S. Customs and Border Protection (CBP), Office of Field Operations (OFO) officers assigned to the Colombia-Solidarity Bridge this week seized methamphetamine in a commercial stone shipment that totaled over $1.3 million in street value. “ …

Distribution channels:

Published on April 2, 2024 - 20:01 GMT

Capital Southwest Receives Affirmed Investment Grade Rating from Moody’s Investors Service

DALLAS, April 02, 2024 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest,” or the “Company”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the …

Distribution channels: Media, Advertising & PR ...

Published on April 2, 2024 - 20:01 GMT

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 2, 2024 - 20:00 GMT

Jeremy Williams Joins Forces with JLA Realty in Strategic Partnership

Jeremy brings a wealth of coaching expertise and a transformative mindset to empower agents at JLA Realty who become part of his team. HOUSTON, TEXAS, UNITED STATES, April 2, 2024 /⁨EINPresswire.com⁩/ -- Jeremy Williams contributes a wealth of experience …

Distribution channels: Business & Economy, Companies ...